Clinical Trials Browser

Phase NA × Kidney Neoplasms × Blood Specimen Collection × Clear all

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms, Melanoma

NCT03787056 2021-07-16

ONCOPRO

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Glioblastoma, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Lymphoma, B-Cell, Endometrial Neoplasms

NCT03185039 2020-01-10

Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angiogenic Agents

Phase NA Unknown

50 enrolled

Genitourinary

Kidney Neoplasms

Clinical Trials

Onco-PDL1s/B2M

ONCOPRO

Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angiogenic Agents